Search
Citas y referencias (25)
Invitrogen™
6-ROX (6-Carboxy-X-Rhodamine), single isomer
Los espectros de excitación y emisión de carboxyrhodamina 6G (CR 6G) se sitúan entre los de fluoresceína y tetrametilrodamina. ConMás información
| Número de catálogo | Cantidad |
|---|---|
| C6156 también denominado C-6156 | 10 mg |
Número de catálogo C6156
también denominado C-6156
Precio (MXN)
-
Cantidad:
10 mg
Los espectros de excitación y emisión de carboxyrhodamina 6G (CR 6G) se sitúan entre los de fluoresceína y tetrametilrodamina. Con una absorción pico a 525 nm, los conjugados de carboxyrhodamina 6G son una excelente coincidencia con la línea espectral de 514 nm del láser de iones de argón. El 6-CR 6G, SE, reactivo a la amina, puede usarse para unir este fluoróforo a biomoléculas de interés, incluyendo oligonucleótidos modificados con amina.
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Reactividad químicaAmina
Emisión525
Excitación514
Etiqueta o tinteROX
Tipo de producto6-ROX
Cantidad10 mg
Fracción reactivaÁcido carboxílico
Condiciones de envíoTemperatura ambiente
Tipo de etiquetaColorantes clásicos
Unit SizeEach
Contenido y almacenamiento
Almacenar en el congelador (de – 5 a – 30 °C) y proteger de la luz.
Preguntas frecuentes
What is the excitation and emission wavelength for rhodamine?
Citations & References (25)
Citations & References
Abstract
Cross-resistance to antifolates in multidrug resistant cell lines with P-glycoprotein or multidrug resistance protein expression.
Journal:Biochem Pharmacol
PubMed ID:9256160
'Resistance to some (lipophilic) antifolates has been associated with P-glycoprotein (P-gp)-mediated multidrug resistance (MDR). A possible relationship with non-P-gp MDR has not been established. We studied resistance to antifolates in SW-1573 human lung carcinoma cells, a P-gp overexpressing variant SW-1573/2R160 and a multidrug resistance protein (MRP) overexpressing variant SW-1573/2R120. In
Down-regulation of topoisomerase II by camptothecin does not prevent additive activity of the topoisomerase II inhibitor etoposide in vitro.
Journal:Anticancer Drugs
PubMed ID:9311443
'Topoisomerases (Topo) I and II are cellular enzymes that catalyze the relaxation of topologically strained DNA and that are involved in a number of DNA-related processes. Their complete inhibition by Topo I and II inhibitors gives promise for improvements in the treatment of malignant diseases. However, preclinical studies showed down-regulation
Evidence for uptake of vital dye by activated rat peritoneal mast cells: an in vitro imaging study.
Journal:Neuroimage
PubMed ID:9343581
'Uptake of material from surrounding medium by activated rat peritoneal mast cells (PMCs) was studied using in vitro peritoneal eluate cells, the vital fluorescent dye sulforhodamine B (SFRM-B), secretagogue compound 48/80, and an imaging technique. PMCs, which undergo different states of degranulation, are shown to possess the ability to take
Toxicity of organic fluorophores used in molecular imaging: literature review.
Journal:Mol Imaging
PubMed ID:20003892
'Fluorophores are potentially useful for in vivo cancer diagnosis. Using relatively inexpensive and portable equipment, optical imaging with fluorophores permits real-time detection of cancer. However, fluorophores can be toxic and must be investigated before they can be administered safely to patients. A review of published literature on the toxicity of
Growth inhibition of human glioma cells induced by 8-chloroadenosine, an active metabolite of 8-chloro cyclic adenosine 3':5'-monophosphate.
Journal:Cancer Res
PubMed ID:1617676
'8-Chloroadenosine 3'':5''-monophosphate (8ClcAMP) inhibits the growth of human glioma cell lines at much lower concentrations than more commonly used cyclic AMP analogues, without inducing morphological differentiation. The mechanism by which 8ClcAMP exerts this effect is not fully understood. We examined whether the growth-inhibitory effect of this compound is due to